Hungary’s first Digital Health conference. Digital health conference for public and private health care, digital pharma, and manufacturers of digital medical products.
Digital Health Market + Digital Health Venture +
Digital Health Startups + Digital Ecosystem +
Public Health Care Digital + Novartis Digital Health
Startup Competition + Roche Personalized Healthcare +
Digital Pharma + Digital Communication for medical doctors +
Responsible Telemedicine + etc.
State Secretary for Health
CEE Digital Lead
Novartis AG, Basel
Digital Health Leader in Oncology, Personalised Healthcare & Patient
Access, Roche, Basel
Corporate Affairs Lead
Biogen Digital Health, Páris
Chief Marketing Officer CEE, MSD
The 1st Digital Health Summit was in February 27th, 2020. We had 297 guests and 31 journalists attended. The 2nd Digital Health Summit was in September, 2021 with 420 guests full house. We sold out the available tickets.
The Digital Health Summit brings together public and private health care, digital pharma, and manufacturers of digital medical products, venture capitalists ynd startups from around Hungary, to network, exchange ideas and to become more familiar with opportunities in Hungary. Our independent conference will become a significant event for many companies in the DH industry and is particularly important in Hungary given the explosion of business and entrepreneurship in the region.
Digital health is the convergence of digital technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and make medicines more personalized and precise. The discipline involves the use of information and communication technologies to help address the health problems and challenges faced by people under treatment. These technologies include both hardware and software solutions and services, including telemedicine, web-based analysis, email, mobile phones and applications, text messages, wearable devices, and clinic or remote monitoring sensors. Generally, digital health is concerned about the development of interconnected health systems to improve the use of computational technologies, smart devices, computational analysis techniques, and communication media to aid healthcare professionals and their clients manage illnesses and health risks, as well as promote health and wellbeing.
Digital health is a multi-disciplinary domain involving many stakeholders, including clinicians, researchers and scientists with a wide range of expertise in healthcare, engineering, social sciences, public health, health economics and data management.
|07.30 - 08.15||Registration, breakfast, networking|
|08.15 - 08.20||Opening - Rita Molnár (DHS, founder)|
|08.20 - 08.40||Teleworking? Then it's telemedicine! - how the development of digital healthcare promotes preventive thinking - Tibor Somogyi (DokiAPP)|
|08.40 - 09.00||Hungarian telemedicine trends in 2021 during COVID - Telemedicine allows health care professionals to evaluate, diagnose and treat patients at a distance using telecommunications technology. As part of the measure related to the epidemiological situation, Decree No 157 of 29 April 2020 was published in the Magyar Közlöny. One of the most important points of the Government Decree is that the personal presence of the patient is not a condition for the provision and financing of the health care service, if the nature of the healthcare and the medical judgment allow it. The use of telemedicine due to the situation became a daily practice for both GPs and specialists in Hungary, and this trend does not reverse. We initiated a representative research by interviewing 600 doctors from 15 specializations to explore their impressions, the pros and cons of telemedicine, and how it can improve the quality of patient care. - Balázs Kertész (Szinapszis)|
|09.01 - 09.21||Immersive VR/AR and mobile solutions in the health sector – DO’s and DONT’s with several use casesImmersive and mobile technologies can be efficiently used in any field of any pharmaceutical companies or hospitals – if they really help the daily operation of the users and the organisation. Our lecture summarizes the practical requirements of several types of digital solutions throughout their development, introduction and daily use – presenting several good and bad examples and using our own IVFSIMPro project as a poster child - Szabolcs Budaházy (ARWorks)|
|09.22 - 09.42||Keynote: Abundant funding to boost research, development and innovation in Hungary - In terms of innovation performance, Hungary is a moderate innovator in the EU, but we aspire to be among the leaders by the end of the decade. According to the latest data from the Hungarian Central Statistical Office, domestic expenditure on research and development has been rising for years, reaching an unprecedented HUF 702 billion in 2019, which is more than double of the 2010 expenditure. Medical sciences and health industry are traditionally outstanding in the Hungarian RDI landscape, but contributions from this sector are even more appreciated due to the coronavirus pandemic crisis. Government funding to foster research, development and innovation sees a significant increase also this year: over HUF 160 billion will be spent from national funds, while the new EU financed operational program will bring further calls worth several hundred billion HUF for the Hungarian RDI ecosystem, just in 2021 alone. - István Szabó, Phd (National Research, Development and Innovation Office)|
|09.43 - 10.03||Keynote: Latest news of digital health development - By the development and nationwide introduction of the National eHealth Infrastructure, Hungary is leading the way in laying the foundation of a digital healthcare system. In terms of digital public services, this infrastructure is still one of Europe’s best. In November 2017, Hungary introduced an accessible and effective digital infrastructure that provides major developments for the domestic healthcare system. Digital solutions and telemedicine both have huge potential for our future society, as the structured collection, storage and lawful utilization of healthcare data represents a significant value. Today the National eHealth Infrastructure (EESZT), operated by the National Healthcare Service Center, is an integral part of healthcare and diagnostic work and is used by physicians and patients as well. - Bálint Szabó (National Healthcare Service Center)|
|10.04 - 10.27||Keynote: Improving patient outcomes and personalising healthcare with digital solutions - Maiko Liebermann (Digital Health Leader Oncology, Personalised Healthcare & Patient Access, Roche) (the pre-recorded presentation is in English, no rendering in other languages available)|
|10.28 - 10.58||Keynote: Pharma Ecosystem Innovation: Value proposition & real life experience - Top 3 highlights and learnings from running open innovation for pharma + to bring some insights/outside-in perspective from The Wide lens theory + Novartis BIOME CEE plans + what we could propose to start today to collaborate with Hungary Startups ecosystem - Mauricio Campos Suarez (Novartis AG, Basel) (the zoom presentation is in English, no rendering in other languages available)|
|10.59 - 11.20||Coffee break, networking|
|11.20 - 11.40||Digital Therapy Planning in Precision Oncology - The challenge of precision oncology is to choose which mutant gene to target with which targeted therapy to achieve response in the presence of the specific mutation and the presence of all the other mutant genes. The solution to this problem is the help of artificial intelligence. Digital therapy planning can potentially increase the efficacy and cost-efficacy of precision oncology.- István Peták, MD, PhD(Oncompass)|
|11.41 - 12.01||Keynote: Digital Innovation in Neuroscience - Madeleine Latapie (Biogen Digital Health, Paris) live Zoom presentation (the presentation is in English, no rendering in other languages available)|
|12.02 - 12.22||Keynote: Straight and honest talk: Artfical Intelligence in healthcare - The future belongs to knowledge-driven and data-intensive solutions. The big question is, how do we move from data to information extraction to greater knowledge, to international research and its exploitation for better healthcare? In this talk, we will explore our real-life experience based the challenges, limitations and opportunities of AI application in healthcare and share human-centric solutions as well. - Antal Kuthy (E-Group)|
|12.23 - 12.43||Understanding the endless complexity of the human body and predicting its diseases - Medipredict is a digital health company providing a comprehensive evaluation of individual health status by combining information from multiple sources, such as detailed medical examinations, medical imaging, microbiome analysis, metabolomics, genomics and processing medical history. Our mission is to help people maximize their health by using cutting-edge technology and evidence-based science to predict disease risk, provide early detection and give actionable insights to maintain optimal health. - Richárd, Kiss, MD, PhD (Medipredict)|
|12.44 - 13.04||New medical technology solutions in remote patient management - Diabetes mellitus is responsible for a huge burden of disease all over the world, including Hungary, as well. Diabetes is associated with an increased risk of numerous serious complications and comorbidities, although the risk is reduced if diabetes is well controlled. Diabetes imposes an increasing economic burden on each country's healthcare system especially due to the treatment of complications. Remote monitoring is not the future any more. Remote monitoring is a clinically proven solution that improves therapy outcomes and follow-up efficiency, while not compromising on safety. - Zoltán Melicher (Medtronic Hungaria)|
|13.05 - 13.59||Lunch, networking|
|14.00 - 14.40||Digital development in Hungary’s health care and health industry: building a digital ecosystem. The role of digitalization: improvement and protection of public health care. What are some of the problems in public health care that can be solved by digitalization? What has been solved already and what still needs to be done? - dr. Zoltán Birkner (NKFIH), Prof. Ildikó Horváth Ildikó, MD, PhD (Ministry of Human Capacities), Bálint Szabó (OKFŐ) - Moderátor: Hatem Lemia (Novartis Hungaria)|
|14.41 - 15.01||Cyber challenges in healthcare. - András Kabai és László Tóth (Deloitte Cyber Risk Services)|
|15.02 - 15.22||Telemedicine with utilization of BigData: COVID applications - The unique insights accessed through BigData are already utilized by healthcare professionals in several disease areas to optimize therapy efficiency and drug adherence. Since the beginning of the pandemic, the potential of telemedicine and BigData are increasingly recognised by decision makers. In times when doctor-patient interactions are limited, the value of monitoring patients' health status remotely via smart devices has significantly increased. How do you utilise a telemedicine infrastructure to gain insights on coronavirus while keeping you patients safe? - Fruzsina Mezei (Omron Medistance)|
|15.23 - 15.43||Attila Ábrahám and Dániel Bálint (Egis Group) presentation|
|15.43 - 16.04||Video-based IoT technologies in healthcare - Attila Szűcs (Konica Minolta Hungary)|
|16.05 - 16.20||coffee break, networking|
|16.20 - 17.00||Digital, Channel & Tech Innovations In Times Of Change: Keep up with business-critical innovation and tech adoption trends. A Look Forward To 2021 & The Future Of Pharma: How has the face of pharma changed, is it embedded and what must we prepare for now? - Pharma Digital panel discussion - Selen Zeydanli Bisson (Merck), Mohamed Kamal (MSD, Zürich), Péter Vereczkei, MD (Pfizer), Moderator: Zoltán Novák, LL.M., PhD (TaylorWessing) (the conversation is in English, no rendering in other languages available)|
|17.00 - 17.45||University education in Health management - Round table with the professors - Prof. Balázs Benyó, PhD (BME), Prof. Miklós Kozlovszky, PhD (Óbudai Egyetem), Prof. Miklós Szócska, MD, PhD (SE), Prof. Péter Mihályi, PHD (Budapesti Corvinus Egyetem) - Moderator: Barnabás Málnay (Smartware.Tech & WS)|
|11.00 - 17.00||Coffee, sandwich, networking, meeting room|
|11.05 - 11.44||A roundtable of Israeli digital health startups - Alon Kushnir (RedDress), Eyal Copitt (Cardiacsense), Jordan Rubinson (PulseNmore) - Moderator: Szabolcs Szolnoki (Science and Tech Diplomat of Hungary in Tel Aviv) (the presentation is in English, no rendering in other languages available)|
|11.45 - 12.21||Venture Capital in the health industry - Gergely Szűcs, PhD (Cashline Holding), Ernő Duda (Solvo) - Moderátor: Zita Albert (Cerha Hempel)|
|12.22 - 12.57||A roundtable of Hungarian digital health startups - Sándor Békási, MD (Fitpuli), Pal Heim (E-Group), Gábor Tóth, MD, PhD (Insimu) - Moderator: Olivér Koppány, Esq. (KNP LAW)|
|12.58 - 13.18||Venture capital investments in digital and offline medical devices - Gergely Szűcs, PhD (Cashline Holding)|
|13.18 - 14.10||Lunch, networking|
|14.10 - 14.55||Put Patients At The Heart Of Your Strategy: Easy-to-use platforms, action-driven strategies and customer-centric comms to boost patient engagement today - Pharma Digital panel discussion - Raffaella Bondi (Roche Hungary), Ákos Kókai-Nagy Ákos, MD (Biogen Hungary), Matt Zeller (Novartis Hungary) - Moderator: József Bulcsú Fenyvesi LL.M. (Oppenheim) (the conversation is in English, no rendering in other languages available)|
|14.56 - 15.12||Eszter Takácsi Nagy presentation (Andrékó Ferenczi Kinstellar Law Firm)|
|15.13 - 15.55||Remote patient follow-up - Monitoring, illness detection and prevention, Capitalize on wearable technologies to continuously monitor and detect illness through real time patient-generated data analysis. Collaborate with industry counterparts including academic medical researchers, patient organizations and pharma - to lead research and pioneer approaches to cancer treatment, diabetology and more. Assess remote and centralized monitoring tools to ensure data quality, site support and patient safety - Péter Becságh, PhD (Roche), Zoltán Melicher (Medtronic Hungary), Barnabás Szabó (77 Elektronika) - Moderator: Kornél Szabó (Sárhegyi Law Firm)|
|15.55 - 16.10||Coffee break, networking|
|16.10 - 16.30||Benefits and challenges of remote patient follow up – a clinician’s view - Patients receiving a cardiac implantable electronic device –e .g pacemaker, defibrillator, event recorder – are an optimal target for remote follow up. The implanted device collects numerous valuable clinical data, which could be collected and monitored in a remote center. Remote monitoring in different patient groups has been effective to prevent hospitalisation and prolong life. Nevertheless, the wider use of the technology is slowed down by several challenges. - Gábor Duray, PhD, MD (zoom presentation) (Honvéd Hospital)|
|16.31 - 16.51||Health Security challenges in the 21st century - Health Security comes to mind most when we are suddenly threatened. Most of us don’t think that the safety of our health, the safety of our health protection and recovery systems, is threatened by global trends. In our presentation, we discuss health security and health security issues along a broader system of aspects. We present the health security aspects of health status, vaccinations and anti-vaccination activism, and data-driven health- and cybersecurity. - Tamás Palicz, MD (Semmelweis University, EMK)|
|16.52 - 17.12||Mit tanulhatunk a Koronavírus fertőzés elleni védekezés menedzseléséből? – Magyar helyzet illetve sikeres védekezést nyújtó országok stratégiája - Balázs Rékassy, MD|
|11.05 - 13.05||Personalized healthcare: from vision to reality? - Cutting-edge technology alone will not provide personalised care to patients: the entire health system needs to undergo profound change. How could it happen? Six leading experts will discuss in an interdisciplinary round-table. - Szabolcs Békássy, MD, Zsolt Horváth, MD, Nóra Bittner, MD, Icó Tóth, Helga Feith, MD, Zsombor Zrubka, MD, PhD (SZEFA Magyar Személyre Szabott Egészségügy Fejlesztéséért Alapítvány / Roche Hungary.)|
|13.05 - 14.00||Lunch, networking|
|14.00 - 16.15||Novartis Digital Health Startup Competition - 6X8 mins Startup Pitch - Juries: Ernő Duda (Solvo), Dándor Varga-Tarr (Hiventures), Krisztián Kölkedi (NKFIH), Tamás Rákóczi (Novartis Hungary)|
|16.16 - 16.36||eHealth literacy: can one have too much of a good thing? - Digitalisation transforms radically health systems and patient-doctor relationships worldwide. People have access to health information without limits, while the paternalistic patient-physician relationship is gradually moving towards a partnership. However, contents available on the internet are frequently inadequate, and can be even harmful. Patients are becoming increasingly responsible for appraising the reliability of information from the internet. From a large national survey we gain overview about the eHealth literacy of the Hungarian general population, and we get insights about its relationship with people’s health status, lifestyle and patient-reported experiences with healthcare - Zsombor Zrubka, MD, PhD (HECON-Health Economics Research Center, Óbuda University)|
Attila graduated as an economist and joined Unilever in 2007, where he could experience and learn the basics of brand marketing and experience-based brand building in various segments and countries. This knowledge greatly helped his path and success in the pharmaceutical industry when he joined Pfizer as a product manager. Experience-based and thus customer-centric marketing has opened new dimensions in the Rx market and are still the most important drivers in his daily work. He experienced very early the analog and digital tools of multi-channel marketing. He had the opportunity to launch second brands, develop integrated marketing campaigns in the generic market, and lead pre-launch and launch activities of a new innovative product. In regional position, the marketing and commercial responsibilities of 53 countries again gave him the opportunity to satisfy his constant curiosity. Before the wave of cultural change with digital transformation hit the industry, one of his biggest professional challenges was introducing a targeted women health portfolio in India. Currently, he has two strategic areas of responsibility; managing the Egis pipeline and monitoring the implementation of corporate strategy in it; the other relates to digital patient-centric solutions. His mission is to build and develop competencies related to digital solutions that enable the development and commercialization of Egis digital patient-centric solutions internationally. He and his team focus mainly on digital ideas that are generated within the company internally.
Zita is M&A partner of CERHA HEMPEL Dezső & Partners Law Firm, with over 16 years of experience in m&a transactions. She has extensive experience in advising on complex domestic and cross border M&A transactions in a wide range of business sectors, including health care. She has led a number of transactions in the health care sector in the past years representing either joint ventures, private equity firms or international healthcare providers.
Leó Asztalos is a final-year medical student at the University of Szeged. During his studies he was part of Szeged Scientist Academy’s scholarship programme. During his scholarship he participated in the work of the Systems Immunology Research Group at the Department of Dermatology and Allergology in Szeged for four years. The main topics of the research were antitumor immunity and infectious diseases. His contribution to the work resulted in co-authorship in two scientific publications, one published in Nature Cancer and the other in PNAS. For two years he also worked as a teacher's assistant at the Department of Physiology in Szeged. In 2021 he received funding from the Hungarian Startup University Program for his startup named BetterDose. Since then he is the CEO of the startup and with his team of four they aim to develop a medtech solution that helps chronically ill people in managing their medication.
Dániel közgazdászként végzett a Budapesti Corvinus Egyetemen, ezt követően nemzetközi mesterdiplomáját a London School of Economics and Political Sciences-en szerezte. 10 éve foglalkozik digitalizációval, fókuszterületei közé tartozik a design thinking, azon belül is a service design és a customer experience, illetve a digitális üzleti modellek. Releváns nemzetközi tapasztalatot az Egyesült Államokban szerzett, ahol digitális üzletfejlesztési projekteken dolgozott Fortune 500 cégeknek. Ezt követően a Telenor digitális termékeinek tervezésén dolgozott az Ügyfélélmény csapat tagjaként. Később az OTP Bank mobil- és internetbank megújítás projektjének egyik munkacsoportját vezette. Gyógyszeripari karrierje előtt digitális transzformációs menedzsment tanácsadóként dolgozott számos hazai és nemzetközi projekten. Jelenleg az Egis nemzetközi digitális betegközpontú megoldásainak menedzsere, illetve a Habita projekt vezetője, mely az Egis Gyógyszergyár első betegeket támogató digitális megoldása.
In the Innovation team at Roche Hungary and at InnoPHC - SZEFA - nonprofit foundation, I am
currently responsible for healthcare innovation. The actual role of the Foundation is to help
transform the healthcare ecosystem by implementing innovative ideas. The first and highlighted
project at InnoPHC / SZEFA is the methodological and digital implementation of the universal
and flexible patient journey centric framework into the Hungarian healthcare operation by co-
creating the digital tool DrBetMen. Originally I graduated as a Biotechnologist - MSc and
obtained my PhD in Molecular Pathology.
Dr. Sándor Békási graduated from Semmelweis University (Budapest, Hungary) as a primary care physician and health manager. After graduation, he was involved in molecular biology research activities, and later, his attention turned to client-centric digital health care solutions and primary care. He is the co-founder and Chief Product Officer of Fitpuli, a Hungarian digital health startup, and chief physician at the Health Center of the Hungarian Charity Service of the Order of Malta. Additionally, he is a member of the advisory board of multiple Hungarian and international digital health startups and an external expert of the European Commission. His main interest is the integration of mobile applications, telemedicine, and remote patient monitoring into traditional medical care pathways.
Prof. Benyó received his Ph.D. degree from BME in 1998 and Dr. habil in 2013. He received Candidate of Science degree from the Hungarian Academy of Sciences in 1998. Between 1998 and 2008 Prof. Benyó was working at the Department of Informatics, Széchenyi István University, Győr where he was the Vice Dean of International and Scientific Affairs and Secretary of the Multidisciplinary Doctoral School of Faculty of Engineering Sciences between 2005 and 2006. Prof Benyó's Selected Major Honours, Awards, Invited Positions and Fellowships: Adjunct Professor/Adjunct Associate Professor (Reader) University of Canterbury, Department of Mechanical Engineering, Christchurch, NZ (2020 / 2013); Eötvös Fellow (by State of Hungary, 2007); “Outstanding creator of the year” (For Technical Development of the Industry Found, 2002); Békésy György Post-doctoral Fellow (by Hungarian Academy of Sciences, 2001); Bolyai János Research Fellow (by Hungarian Academy of Sciences, 1998); Soros Short Fellow (Soros Foundation, 1993); Invited Guest Editor of three Special Issues of biomedical engineering journals (Journal of Biological Signal Processing and Control, Control Engineering Practice); Co-Chair of International Federation on Automatic Control (IFAC) Technical Committee 8.2 Biological and Medical Systems. His research interest includes, among others, the modelling and control of physiological systems, model based medical diagnostic and treatment solutions, metabolic control; Nuclear medical imaging, image reconstruction algorithms, parallel implementation of SPECT reconstruction in GPGPU platform; Medical image processing, fuzzy methods, image based medical diagnostics, medical informatics; Mobile and contactless technologies (including Near Field Communication Technology) to create novel technological solutions and services, system security, safety critical solutions. Prof Benyó is the leader of the Biomedical Engineering Laboratory at the Department of Control Engineering and Information Technology working in theoretical and applied research in biomedical engineering and medical informatics for 15+ years. The Laboratory provides the basic infrastructure for Biomedical Engineering training at the Faculty of Electrical Engineering and Informatics. Prof Benyo is the leader and/or participant of several successful OTKA (Hungarian Scientific Research Fund), EU financed national (GVOP) and international (Copernicus, FP6, FP7, H2020) projects, and is coordinator of the DCPM: Digital Clone for Personalized Medicine (EU H2020-MSCA-RISE-2018 call, Grant ID: 872488). Prof. Balázs Benyó has published more than 350 scientific publications, received more than 1800 references, his h-index is 21.
Szabolcs Békássy, MD graduated as a medical doctor in 2007. He has been working as a general practitioner in Dunavarsány since 2008, qualified in family medicine in 2011 and in occupational medicine in 2017. He is the founding president of the Online Organisation of General Practitioners (Háziorvosok Online Szervezete, HaOSZ) and has been active in the Hungarian Medical Chamber since 2015. Since 2021, he has been a PhD student at the Faculty of Health Sciences at the University of Pécs as well as the the National Collegial Head of General Practitioners of the Directorate for Primary Care Development at the National Directorate General for Hospitals.
His professional career demonstrates thorough experience in higher education as a lecturer and education organiser, in scientific life as a researcher of innovation management, and in the business sector as a manager dealing with organisational and business development and industrial research and development projects.
Nóra Bittner, MD graduated from Semmelweis University of Medicine in 1989. Afterwards she lived in Pécs for 10 years and specialised pulmonology. Early on, she focused on the care of oncological patients. She also gained experience as a clinical research manager and medical consultant in multinational pharmaceutical companies. In 1999, she obtained an MBA from the University of Pécs, specialising in health economics. After returning to Budapest, he worked at the National Oncology Institute for 12 years as a senior oncologist. Her main areas of research and care were lung, breast, colorectal and rare cancers. She participated in and led several clinical research projects and obtained a specialization in clinical pharmacology. She defended her PhD in 2015 on the association between EGFR mutations in lung tumours and bone metastases. Throughout her career, she has considered patient collaboration, communication and patient information as key priorities. She has collaborated with patient organisations to promote health, primary prevention and early screening. She has acted as an expert consultant in several oncology development projects. In Debrecen she was Director of the Pulmonary Clinic for 3 years. Currently she is an Associate Professor at the Department of Internal Medicine and Oncology of Semmelweis University.
Raffaella Claudia Bondi is an experienced pharmaceutical executive, with 20+ years in marketing and commercial roles, across several health-related businesses. She has been working at Roche for nearly 20 years. From diagnostics via the pharmaceutical industry to diabetes care, she gained experiences in many areas. She began her career in Italy, her home country, then held various positions at the affiliate in Denmark. In Switzerland, she became responsible for the entire European region, since November 2021 she is the General Manager of Roche Hungary. Passionate about partnering for better patient outcomes. She’s committed to co-creating with different stakeholders across the Hungarian healthcare ecosystem to ensure sustainability, access as well as boost innovation.
Szabolcs Budahazy is the founder and CEO of ARworks, the AR/VR and mobile app developer company serving clients since 2010. ARworks’ team of 50 is a the leader of the Hungarian Virtual and Augmented Reality development market and among others have long experience in health and pharma related solutions. Besides the local market, ARworks has a strong presence in other foreign markets as well – like the UAE or Kuwait.
One of their biggest clients is Novartis’ HQ in Basel but they developed projects for several other pharma companies as well. Among others there is a symptom tracker app for patients, a training app for nurses on the preparation of a drug, or an app helping patients and their families coping with a certain disease.
VR technology gaining more and more ground in trainings. A good example for this is IVFSimPro, ARworks’ in-vitro fertilisation training simulator. The solution is launched during the Summer 2021 and helps professionals to learn the IVF process using either a VR headset or a simple browser based solution running on their laptop.
Over the past 20 years, Eyal Copitt’s professional experience has focused on international business and technology covering multiple disciplines, including satellites, data storage, bandwidth optimization and in the last years in pharma and medical devices. His management success is a function of his sharp analytical skills, long-term vision, and expertise in Go-to-Market strategy planning.
He is a serial entrepreneur and investor, he has founded or co-founded over two dozen companies. He’s the founder and CEO of Solvo Biotechnology, the largest biotech company in Hungary. He is the founder and president of the Hungarian Biotech Association and of Medipredict, a company in the personalized health prevention and prediction field. He is an investor in 20+ startups and focuses on early stage companies in the areas of life sciences/medtech/AI/blockchain. He is an associate professor at the University of Szeged since 2003, where he teaches Biotechnology and Entrepreneurship and he also gives lectures at the Aquincum Institute of Technology. He is the founder of a school in Szeged, called Szikra. Szikra is a practical and experience-centered nonprofit institution, its goal is to become a world class primary and secondary school.
Belgyógyász – Kardiológus, nemzetközileg jegyzett szívritmuszavar specialista. Általános orvosi diplomáját a Semmelweis Egyetemen szerezte, majd a szakképzése után 2005 és 2010 között a Frankfurti Egyetem Kardiológiai Klinikáján dolgozott, ahol a szívritmuszavar részleg főorvosaként dolgozott. Európai Kardiológus diplomát szerzett, majd az Európai Kardiológus Társaság tiszteletbeli tagjának választotta. A Semmelweis Egyetemen szerezte PhD doktori (2009) címét, Egészségügyi Menedzser MSc diplomáját (2019), majd ugyanitt habilitált (2020). A Magyar Kardiológusok Társasága Aritmia és Pacemaker munkacsoport alelnöke. Kutatási érdeklődési köre a szívritmuszavar, valamint szívelégtelenség miatt eszközös kezelésre szoruló betegek ellátási módszerei, a katéteres, műtéti (pacemaker, defibrillátor), valamint gyógyszeres kezelési stratégiái. Bevezette Magyarországra a legmodernebb, teljesen a szívbe ültethető törpe pacemaker (Micra) alkalmazását, és tapasztalataival nagymértékben hozzájárult a technológia széleskörű elterjesztéséhez. A mindennapi betegellátás mellett fontos számára az eszköz- és gyógyszergyártókkal való szoros együttműködés, a diagnosztikus és terápiás eljárások kifejlesztésével és alkalmazásával kapcsolatos kutatómunka.
She is a college professor, head of Department of Social Sciences, Faculty of Health Sciences, Semmelweis University. She has master degrees in history, sociology and law, she is a lawyer specialized in health care. Her main fields of research: legal aspects of patient care, history of Hungarian health care law and measuring the effectiveness of school health promotion programmes.
Graduated from the Janus Pannonius University of Pécs in 1998 and pursued postgraduate studies in EU law at the University of Pécs. Obtained an LLM in International Economic Law at the University of Warwick in 2004. Attended the University of Oxford as a Chevening scholar and received a Magister Juris degree in 2006. Joined the Budapest office of Freshfields Bruckhaus Deringer in 2005. Associate of Oppenheim since 2007, partner at the firm since 2010. Head of the Corporate practice of Oppenheim since 2014.
Areas of specialization: Company Law, M&A, Capital MarketTransactions.
Sector experience: Capital markets, Chemicals & Pharma
Languages: Hungarian and English
Lemia is an economist, graduated from Corvinus University of Budapest. After a short time spent in FMCG (Unilever) she immediately jumped into the world of pharmaceuticals where she’s been since 11 years now. After several roles in Communications and Public Affairs at Sanofi where she also spent a year in Sofia, Bulgaria; she joined MSD as Policy and Communications Lead where she was heavily involved in shaping public discussions around HPV vaccination and lung cancer. She is currently heading Public Affairs, Communications and Advocacy at Novartis Hungary. Lemia is passionate about public health issues, especially addressing health literacy & education and she’s a strong believer in the change civil society and patient advocates could make.
A Heim Pál Magyarország Alapítvány stratégiai igazgatója és tiszteletbeli elnöke. 2011-ben megalakította a Mesekórház Program-ot, amely a beteg gyerekek kórházi gyógyulásához kapcsolódó pozitív vizuális élményeket helyezi előtérbe a technológia segítségével. 2012-2016 között a Heim Pál Gyermekkórház Jószolgálati Nagyköveteként dolgozott a legnagyobb hazai gyermekkórház pályázati forrásokból megvalósított fejlesztésén. 2013- tól a Heim Pál Magyarország Alapítvány stratégiai igazgatója, tiszteletbeli elnöke. 2016-2018 között a Digitális Jólét Program (DJP) Digitális Egészségipar-Fejlesztési Stratégia (DEFS) szakmai vezetőjeként a Heim Pál Magyarország Alapítvány kapott felkérést a stratégiát előkészítő tanulmány elkészítésére is. Szakmai vezetőként dolgozik az E-Group Zrt. digitális egészségügyi inkubációs projektjein, melyben az OkosKlinika digitális okos egészségügyi megoldása is kiemelt szerepet kap. 2014 -ben társalapítóként vett részt a Magyar Elektromobilitás Szövetség létrehozásában.2019 végétől az önfenntartó és energia független életvitel népszerűsítésében vállal szerepet. Eddig két alkalommal kapta meg a dédnagyapja nevét viselő Heim Pál Díjat, először 1997-ben a Heim Pál Gyermekkórházért végzett tevékenységéért, majd 2014-ben a Magyar Gyermekegészségügy Fejlesztésében végzett több évtizedes munkájáért és a Mesekórház Program létrehozásáért. Nemzetközi hírnevet szerzett csecsemőgyógyász Dédnagyapja szellemi örököseként a gyermekek korai szemléletformálásában és a személyes példamutatás erejében látja a fenntartható jövő legfőbb alapjait.
Zsolt Horváth, MD graduated as a medical doctor in 1989, and subsequently qualified in internal medicine, clinical oncology, clinical pharmacology, as well as obtained the ESMO Certification in Medical Oncology and license in palliative therapy. He obtained his PhD in 2011 and MSc in healthcare management in 2016. From 1989 to 2012 he worked at the National Institute of Oncology, from 2021 to 2017 he was Director of the Oncology Institute of the University of Debrecen, from 2017 he was Chief Physician of the National Institute of Oncology, and from 2018 he has been the head of the Oncoradiology Centre of the Bács-Kiskun County Teaching Hospital. He is a member of several Hungarian and international professional organisations and working groups, as well as the editorial boards of the Magyar Onkológia and Onkológia journals.
Andras is a Director in Deloitte Cyber Risk Services team with over 18 years of experience in IT security. András is recognized as an international expert in penetration testing, exploiting and assessment. He has strong automotive security testing experience with connected vehicles, automotive specific buses and components.
He is the designer and lecturer of custom car hacking and hardware hacking training programs (including custom electronics, PCBs, simulated ECUs) made for different Automotive OEMs and other clients. Andras established and leading Deloitte Hungary’s hardware hacking service line and he is also responsible for the cyber practice’s IoT and car hacking services. He and his team delivered hardware hacking projects worldwide and have clients from Automotive, IoT and FSI sector.
Prior to joining Deloitte Andras was the lead IT security expert at CERT-Hungary / National Cybersecurity Center and participating in several penetration tests and other IT security projects.
Andras is a regular lecturer and presenter on IT security conferences and professional events.
He holds various industry recognized certificates: OSCP, OSCE, OSEE, GPEN, GWAPT, GREM, GXPN, CEH
Balázs has an MA in Economics and works for Szinapszis from the beginning as the professional leader of researches, also responsible for internal innovation and international relationships. Balázs is a developer Szinapszis’ branded pharmaceutical solutions and research models. Main research areas: sales force effectiveness, pharmaceutical targeting, segmentation, KOL mapping, price sensitivity tests, MCM and digital transition in the pharma industry. Presenter on various Hungarian and International conferences, member end representative of Szinapszis in the European market research associations (ESOMAR, EphMRA).
Dr. Richard Kiss earned his medical degree from Semmelweis University, after which he obtained a PhD degree from the MTA-SE Momentum Molecular Oncohematology Research Group. His research topic was the mapping of the genetic and epigenetic background of leukemias and lymphomas, during which he gained extensive experience in the application of molecular genetic methods to support the personalized treatment of hematological malignancies. During his studies, he gained professional experience in Taiwan, Germany and the Netherlands, and is a frequent speaker at Hungarian scientific conferences as well as at patient education and scientific events. As the leader of Medipredict’s medical team, he works to integrate the results of state-of-the-art medical testing with omic studies to identify individual disease risks and develop personalized intervention options.
Dr. Ákos Kókai-Nagy is currently the Country Director of the Hungarian Affiliate of Biogen
pharmaceutical company since 2017. Also, he is a Board member of the Association of Innovative Pharmaceutical Manufacturers (AIPM) since 2017, and the elected President of the organization since
2020. Dr. Ákos Kókai-Nagy graduated from Semmelweis University and, after several further courses, he graduated in 2012 with an EMBA qualification from Purdue University International Master of Management. During his career, he has held management positions at several pharmaceutical companies both in Hungary and abroad, including since 2012 he has been the Managing Director of Astellas Pharma in Denmark.
After dealing with own startups he got involved in business development, then carried on as an organization development coach and top management adviser. Currently he is engaged in launching innovation services for the Hungarian ecosystem, which includes a mission to boost youth and startup programs. Created with his supervision, the Hungarian Startup University Program now plays a key role in promoting entrepreneurship and innovative mindset among Hungarian university students.
Olivér Koppány is a lawyer who’s main focus is on issues involving cross-border pharmaceutical transactions, start-up’s legal matters, international commercial contracts and matters that concern the United States and Hungary. He is admitted to the District of Columbia (Washington DC) Bar and the Budapest Bar Association as a Foreign Legal Councel. KNP LAW’s main profile is Pharmaceutical & Life Sciences Law, including competition law issues, regulatory and pharma-marketing matters. They regularly represent and advice pharmaceutical companies, health care providers, and other key players in the pharma industry.
Dr. Miklos KOZLOVSZKY is a full Professor at Óbuda University (Hungary), head of the BioTech Research Center (BTRC) and the John von Neumann Faculty of Informatics, besides that he is working as Senior Research Fellow at the Laboratory of Parallel and Distributed Systems in the Computer and Automation Research Institute of the Hungarian Academy of Sciences. He is full professor (since 2020) and received his habilitation (in 2017) at Óbuda University. He received his PhD from the Budapest University of Technology and Economics (Hungary) in 2009, and his MSc in Computer Science from the University of Szeged (Hungary) in 2001. He is a lecturer at various Universities: at Óbuda University (Hungary) since 2005, at Semmelweis University (Hungary) since 2015 and at National University of the Litoral (Santa Fe, Argentina) since 2017. Before that, he was working: as researcher in the Bioinformatics Group at IMP /Research Institute of Molecular Pathology/ (Austria), at CERN /European Organization for Nuclear Research/ (Switzerland), and as team leader at Vodafone Hungary (Hungary). During last 20 years he was involved in many EU FP6, FP7 (SHIWA, HP-SEE, SEE-GRID-SCI, EGEE, EGI, …) and H2020 projects at various positions (deputy project leader, WP leader, engineer, etc.). He is author and co-author of 180+ research articles in peer-reviewed journals and books.
Dr. Sándor Kulin graduated as a medical doctor in 1990 at Semmelweis University, Budapest, and became an obstetrician and gynecologist at Imre Haynal University of Health Sciences in 1994. As a gynecologist who has the super specialization for Infertility care, personally performed over 3000 IVF cycles and have a special focus on maternal and infant health. Actively participates in many research projects in a wide range from in vitro cell cultures to phase IV clinical trials. Has special interest in maternal and fetal health, human physiology, cell physiology, hypoxia, malignant transformation, and therapy monitoring. Lecturer in various international conferences and author of several publications. Having almost 20 years of experience in non-invasive cardiovascular monitoring in 2018 he became a Co-founder and CEO of E-Med4All Europe Ltd, a Hungarian digital health startup, aiming to help the transformation towards a more data driven and personalized medicine and to be part of the shift of today’s medicine from disease management to prevention.
Entrepreneur and founder of several successful medical device startups for the past 22 years. He is the founder and CEO of RedDress ltd, leading it from an idea a to successful commercialization around the world. Earned two BAs with honor in computer science and life science from Bar Ilan university, Israel. He led the design and conduct of over 60 clinical studies in North America, Asia, Europe and Africa and has 16 medical patents in various fields, including pulmonology, cardiology, interventional cardiology, urology, dermatology and Gynecology.
M.Sc.E.E. Telecommunication Engineering and Computer Science, Budapest University of Technology, informatics class, thesis in machine learning, speech recognition and natural language processing, Tangora System – IBM R&D Heidelberg. Postgrad program, EIPOS Institute (DT), Germany. FCO Chevening Scholarship in financial economics, thesis in game theory, UCL, London. Research in computer science, NTT Research, Tokyo / Tennesse Tech, US. ProScientia Medal – national science competition in engineering,
In 1993, he founded E-Group as a fresh graduate with his classmate and friend, András Nagy. Antal moved to Hong Kong, where he established the Eastern presence of E-Group by creating E-Group Asia and E-Group Vietnam. Ever since returning to Budapest with his family, his mission is to take E-Group to the next level.
As the Chief Executive Officer, Antal represents strategy, innovation, sales and business development in the management and advocates the ‘data to knowledge with trust’ vision. With his proactive attitude and invaluable insight into the market, Antal drives new co-innovation opportunities and facilitates lab-to-market models with the academia and industry successfully.
As an ex modern pentathlete, he loves to go on morning runs. He is eager to meet smart people and drink tea from his favourite china set. During the evening, his three sons keep him active.
Barnabás Málnay is partner at the startup seed investor Smartware.Tech and business development advisor at ELTE's School of Engineering. Earlier he was business developer at the pan-European digital innovation and international business development organization EIT Digital, managing director at the Hungarian Mobility and Multimedia Cluster, partner at the startup advisory and investment formation White Summers Cofounder; business development director at AVEC, a startup accelerator launched by one of Hungary’s then largest VC groups, the DayOne-Portfolion Group; director of external relations and development at Kitchen Budapest, Magyar Telekom’s innovation lab; and senior advisor at Magyar Telekom’s Innovation and Business Development Directorate. He studied social and political theory at ELTE and CEU in Budapest, and at Stanford University, where he also worked as a teaching assistant and instructor in various teaching programs.
Melicher Zoltán graduated as electrical engineer and later as biomedical engineer at Budapest University of Technology and Economics. Started his career in the automotive industry, but moved to Medtronic in 2009 as a technical specialist and supported hungarian clinics and physicians in the implant and the care of cardiac device patients. Zoltan was responsible for developing the remote monitoring solution of Medtronic in Central Eastern Europe, Russia and Central Asia. He is currently leading the Cardiac Rhythm Management business in Czech Reublic, Slovakia and Hungary at Medtronic.
As a Health Policy Expert of the Hungarian National Public Health Centre since 2017, Fruzsi is strategically planning and implementing evidence-based developments in the field of primary care. She is currently working on improving care of six chronic disease groups that are leading causes of death in Hungary (e.g. hypertension, diabetes, oncological diseases etc.). She graduated as a Medical Anthropologist from Durham University in 2017 and received her MSc in Health Policy, Planning and Financing from ELTE in 2019. Stemming from her research background, she is an advocate of evidence-based policy making and aims to disseminate the idea of data collection and analytics to systematically address leading health issues. Working on national and international health care projects, primarily in the field of chronic care, she has first-hand experience in the barriers of implementing innovative digital solutions in the public health sphere. She works to overcome these barriers.
He started his academic career after graduation from the Karl Marx University of Economic Sciences in Budapest. Between 1983-1993, he was a researcher of the UN Economic Commission for Europe in Geneva. After returning to his native country, he became an active participant of the Hungarian privatization process. He served – inter alia – as Deputy Government Commissioner for Privatization in 1994/95 and played a major role in the largest transactions in energy and banking. In 1997/98 he was promoted to Deputy State Secretary in the Ministry of Finance. His portfolio included the pension reform, the preparation of the healthcare reform and municipal financing.
Professor Mihályi has more than two decades of experience in teaching health economics at BA, MA and PhD levels. Since 2012, he is Editor-in-Chief of Acta Oeconomica, an English language academic quarterly with an impact factor (2019: 0.914).
During the last 15 years, Professor Mihályi's research has been focused on health policy issues. He is currently affiliated with the Corvinus University of Budapest as tenured professor of the Economics Department and the Central European University as a Recurrent Visiting Professor since 1996. Professor Mihályi is an often consulted expert by UNCTAD, UN ECE, the World Bank and the European Union. He authored 12 books, from which five dealt with healthcare. His most recent English-language book is entitled, Health Insurance Reform in Hungary, Vol.1-2. In 2006-2008, he was the Personal Advisor of two successive health ministers in Hungary. Simultaneously, he was Leader of the Health Committee within the State Reform Committee. During the recent COVID-19 crisis, Professor Mihályi published several articles in the Hungarian press in order to inform the public about the most recent scientific findings.
Rita Molnar earned her BA business communication degree in the Budapest College of Communication and Business in 2008. She completed her MBA master program at Budapest Metropolitan University in 2020 and she is now pursuing a Health Policy, Planning and Financing Master’s program at Budapest Corvinus University. The program is designed to provide you with a comprehensive understanding of the complexities of health care systems both at macro- and micro-levels within the context of technological development, an ageing population and patient expectations. She is well-prepared to work in health administration, government departments, research and consultancy agencies, universities, national health services, health care organizations and pharmaceutical and medical device industry.
She started her career as a professional photojournalist from 1997 to 2002. Rita was just 21 when she started organizing events, and she founded her own company. Her first event was an amateur film festival in Eger in 1998. Ever since, she has been organizing 3 conferences per year, mainly in healthcare and VC investing fields. Between 2001-2005 Rita also worked as a movie producer. She was involved in co-producing a movie directed by the iconic Magyar movie-maker Miklós Jancsó. From 2006 to late 2007 Rita managed the event marketing team at Ringier Publishing, a Hungarian subsidiary of a Swiss-based leading publishing firm. In the summer of 2010 Rita founded Slimexpo with a venture capital involvement, and she organized with her own team a Slimexpo Festival with a diet, health and beauty theme at a premium event venue in Budapest Aréna in the spring of 2011.
After having a successful sports career he graduated at Semmelweis University Physical Education and Sports Science Faculty of Recreation Organization and Health Promotion. He started his „civil” career at European Health Communication Center where he founded his commitment to he developement of private health in Hungary. Founder and owner of several successful small businesses in Hungary. For example Fulltakarítás, founded in 2007, which serves over 100 private and corporate clients, or Kalóz Strandbisztró which was founded in 2013. With the latter, his aim was to create a new type of Balaton Beach gastronomy which is confirmed by several professional success and awards (Balaton Beach Food Award of the Year 2015., Dining Guide Hungary Top 10 Alternative Restaurants Award 2017., 2018., 2019., 2020., 2021., Hungarian Cuisine Top 10 Balaton Beach Buffet Award 2016., 2017., 2018., 2019., 2020., 2021., The Association for the Life-Giving Balaton Uplands Rural Quality Trademark 2015.)
Zoltán obtained his law degree in 2009 from the University of Debrecen. He also studied in Tübingen, Leuven and Amsterdam. He holds an LL.M in International Dispute Resolution from Queen Mary University in London and defended his PhD in 2011. In 2014, he successfully passed the bar exam.
He acquired his first professional experiences in the German Federal Parliament. In 2010 he started his career as a lawyer. Since 2018, he has been a partner at Taylor Wessing Budapest.
He specializes in pharmaceutical law, intellectual property law and dispute resolution and regularly provides legal advice to international pharmaceutical and tech companies on corporate, marketing authorization, intellectual property and labour law matters. In addition, he has extensive international litigation and arbitration experience.
Zoltán is the author of several publications. His academic articles have appeared in the journal “Gazdaság és Jog”, the Oxford Journal of Intellectual Property Law & Practice and the Kluwer Arbitration Blog, among others.
In 2018, he and his colleagues won the Wolters Kluwer Lawyers’ Award in the category of intellectual property law.
Dr. Tamás Palicz obtained his doctoral degree in medicine at the University of Debrecen in 1993, then in 1998 he became a specialist in internal medicine at the 3rd Department of Medicine of Semmelweis University. After several years of clinical practice he started to plan, implement and monitor EU-funded projects. He has been working as a manager since 2003, initially as Deputy Director General of the Directorate General for Strategy and Operational Development at Semmelweis University, and from 2005 as Medical Director of the Kútvölgy Clinic. Between 2010 and 2013, he was the Head of the Managing Authority for Human Resources Development and Renewal Operational Programs (TIOP and TÁMOP) of the National Development Agency, which was responsible for planning and monitoring the implementation of these projects. From 2013, he worked for two years as the Deputy Director General of the National Institute for Health Development and as the professional leader of the TÁMOP-612A-14/1-A project, where he was responsible for the introduction of school health promotion. Since the end of 2015, he is the Deputy Strategic Director at the Health Services Management Training Centre of Semmelweis University, where he earned his Masters's degree in Healthcare Management in 2001.
His main areas of interest are process-oriented management of healthcare organisations, leading organisational changes and project management in healthcare. In recent years, in the context of the digital transformation of healthcare, he has begun to address cybersecurity issues within healthcare organisations.
Istvan Petak, MD, Ph.D., is a physician and researcher. He has been developing technologies together with his team to find the best personalized, targeted therapy for cancer patients for over 20 years. His group was one of the pioneers of predictive molecular diagnostics. Their current development is a method to match the best, targeted therapy to each genetic alterations or combination of genetic changes in every cancer patient. This technique is being implemented into an artificial intelligence-based medical software system. This system and method received the award of the American Society Clinical Oncology at their Breakthrough Oncology conference in Bangkok, and it also won the innovation prize of the GET IN THE RING V4, in 2019. Dr. Petak is the founder and CEO of Oncompass Medicine and regular lecturer of the Semmelweis University, Budapest, and the University of Illinois at Chicago.
Tamás graduated as an economist and began his pharmaceutical career at Pfizer in 2009. During his more than 10 years there, he gained extensive experience in various departments (Finance, Business operation, Global Commercial operation), which was later utilized in the field of sales force excellence and he also played a decisive role in the company's digital development and implementation of new systems. After nearly 10 years on the support side, he had the opportunity to prove his abilities on the business side, for a year and a half in the Internal Medicine business unit he was responsible for promoting selected products through digital channels. He joined Novartis’s cardiovascular business unit as a product manager in 2020 and will continue his career in the Digital Lead position from 2021, where his main responsibilities will be the company’s digital development, mapping and implementing new, innovative opportunities and transforming the Omnichannel approach theory into practice.
Balazs has been graduated at the Semmelweis Medical School in 1992, then he got a further MSc degree at the London School of Hygiene and Tropical Medicine & London School of Economics and Political Science, Public Health and Policy Health Care Management, where he has continued his further studies at the Health Services Research Unit. Furthermore he has also graduated at the Eötvös Lóránd Science University Faculty of Social Sciences Health Economics Task Force on Drug Policy and Pharmaceutical Economics. His work experience encompasses wide range of health care sector: He has served as a General Practitioner, managing a public health institution, worked at the Ministry of Health, World Bank Public health programs, and also used to be director at the Pharmaceutical sector, as well as Private Health Insurance, Health Fund. He is proud to be the founder of the first Hungarian private health insurance providing in-kind care, or establishing health fund, and also he has participated in the foundation of the first Hungarian Fund Holding primary care model. With his 12 colleagues he is managing a medical devices distributor firm, besides he is providing health economics, health care management, health policy advices to several health insurance companies, health care providers. He is also the health policy advisor of the Major of Budapest.
Jordan Rubinson has more than 20 years of experience in the pharmaceutical industry with large pharma companies like Pfizer, GlaxoSmithKline, and Aventis. He recently worked in early stage companies as a CEO of Regenera Pharma, as a Chief Commercial Officer for Champions Oncology, and was also the CEO of Polyheal Ltd, which was sold to TEVA at a $90M valuation. He worked at Pfizer as the marketing director for Israel, at GSK in U.S. marketing, and at GSK France, managing a large field force division of over 100 employees. While at Aventis, Jordan had assignments in France, Canada and the U.S. He holds an engineering degree from Columbia University and an MBA from MIT.
Tibor is an economist and digital serial entrepreneur, with projects such as the easyMaths online education portal, where more than 100,000 students prepare for his exams each year, and startuptanacsadas.hu, where they help start-ups and scale-ups succeed in entering or scaling up the market. In 2017, Forbes selected him as one of the 30 successful young people in the under 30 list. Based on his experience in his environment and on his own skin, he brought to life the DokiApp healthcare application, which drastically shortens the path to primary medical opinion by allowing a patient to consult with a specialist or psychologist via video consultation within 30 minutes. He always becomes obsessed for the industry in which they operate, so through DokiApp he researches the latest telemedicine solutions.
Bálint Szabó is head of division at the National Healthcare Service Center (ÁEEK). He graduated at Eötvös Lóránd University, Budapest Technology University and Kossuth Lajos University.
He is responsible for the establishment and operation of the National eHealth Infrastructure (EESZT), As the leader of the program aimed at establishing the future of e-health, he led the development of the EESZT, and now he leading its ongoing operation. This is solidly based on his professional background that includes experience in software development project management in various industries, as well as enterprise IT operation management. He regularly presents at IT conferences and he is the author of several professional publications.
Barnabás is an engineer-economist with extensive experience in the medical device and diagnostics field.
He graduated from the Budapest University of Technology as a mechanical engineer in 2003 and did his postgraduate studies at the Budapest Corvinus University.
He started his career at the Budapest University of Technology, where he was involved in an international cardiovascular stent research and development project.
In 2007 he began to work at MED-EL GmbH. in Austria as a development project lead in the implantable neurostimulation field.
In 2011 he joined the Hungarian In Vitro Diagnostic company 77 Elektronika Kft. as diabetes topic manager and became soon deputy director of the Development Department. His responsibility is cross-functional device development of multiple product lines from idea to market release in international environment, including quality and regulatory aspects. His main area is Point of Care Testing and related digital health technologies.
Barnabás is a strategic planner with a high focus on medical product related innovation.
He is married and father of 3 children.
Közgazdász végzettségű szakember, három éve az NKFIH tudományos és nemzetközi elnökhelyettese, aktív kutató, kutatásainak fókuszában a kutatási infrastruktúrák állnak. Küldetése Magyarországi KFI-eredményeinek és világszínvonalú kutatási infrastruktúráinak nemzetközi szintű láthatóvá tétele, ezen keresztül a szélesebb körű kutatási együttműködések ösztönzése.
Kornél Szabó (University of Szeged, Kings College London) has 20 years' professional experience in international environment and 'magic circle' law firms in Budapest and Brussels in the fields of private equity, M&A, capital market transactions and regulatory matters.
He is the Deputy Managing Partner of Sárhegyi and Partners law firm (a top ten largest law firm in Budapest) and the CEO of the technology (aerospace) focussed fund management firm, Herius Capital.
Miklós Szócska, MD graduated at the Semmelweis University (SU) of Medicine in 1989. He holds a Master of Public Administration degree from the John F. Kennedy School of Government at Harvard University (1998), and a Ph.D. from the SU in the field of change management (2003). After his graduation at the SU he and his colleagues initiated the creation of the Health Services Management Training Centre (officially established in 1995). Between 1995 and 2000 he was serving as the deputy director and in 2000 he was appointed to be the director of the Centre. Between 2010-2014 Dr. Szócska served as the Minister of State for Health of the Hungarian Government. Since 2014 he serves again as the Director of HSMTC and became responsible for the Institute of Digital Health Sciences at SU. In 2016 He was nominated by the Hungarian Government for the DG position of the WHO. In July 2019 Dr Szócska was appointed to be the Dean of the Faculty of Health and Public Services at Semmelweis University.
Adapting to the characteristics of the Israeli ecosystem as the Science and Technology
Attaché of Hungary in Tel-Aviv he focuses on projects of applied research, experimental
development and startup cooperation. One of the flagship frameworks supporting the joint
RDI activities is the Hungary-Israel call for proposals in industrial research and development
published on annual basis. As a priority taks Mr. Szolnoki assists the interested companies in
searching partners. The areas of cooperation and interest mainly are: life sciences, digital
health, cybersecurity, mobility and autonomous vehicles, space-industry. Szabolcs Szolnoki is
a doctoral student at the University of Pécs, Insititute of Geography and Earth Sciences.
Before his diplomatic service he assisted innovative Hungarian inventors in starting their
businesses and entering domestic and foreign markets.
Közel 20 éves biztonságtechnikában töltött pályafutása során bejárta a teljes láncolatot. Végfelhasználói, rendszerintegrátori, disztribútori és gyártói tapasztalatokkal felvértezve célja egy olyan szolgáltatási kör felépítése, ami a mai kor igényei mellett igyekszik megoldást találni a jövő szükségleteire, problémáira is. Korábban a legnagyobb hazai nagyvállalat életébe vitt világszerte egységes videós biztonságtechnikai megoldást, növelve a hatékonyságot, minőséget. Jelenleg elsődleges feladata, hogy a hazai piacon megmutassa, hogyan lehet újító szemléltet vinni a partnerek és végfelhasználók életébe azzal a különleges portfólióval, amit a Mobotix jelent az IoT video világában.
He graduated at the Budapest University of Economic Sciences and Public Administration as a financial investment analyst and risk manager in 2003. He has more than 12-years experience in venture capital and private equity investments, as well as, strategic and financial management of companies. Between 2003 and 2007 he worked for the Hungarian Development Bank (MFB) and MFB Invest Zrt. His position was investment analyst, he was responsible for the analysis of development plans, company valuation, the support of the operation of the portfolio companies, and the exit from the investments. He is working for Cashline Group since 2007 as a portfolio-manager, active in the deal flow generation, project analysis, valuation, management of the entire investment and exit process, as well as, strategic management of the portfolio companies. Since 2012 he is responsible for the venture capital activity of Cashline Group, and is the CEO of Valor Capital. He completed a Ph.D. Program at Corvinus University of Budapest, on the Department of Environmental Sciences and Technology in 2015. His research topics are environmental innovations and patents. He is managing director and board member of numerous Hungarian small and medium-sized enterprises.
She is a Hungarian attorney with over 14 years of experience having in-depth knowledge
pharmaceutical, biotechnology, healthcare and medical devices sectors and the related regulatory
Eszter also regularly advises on competition and state aid matters, and has leveraged that experience
to deliver a broader and deeper service offering to the firm’s life sciences clients. Her client base
includes national and international clients in respect of which she has advised on licensing,
compliance, enforcement as well as sector related M&A.
Eszter was named Regulatory Rising Star at the LMG European Life Sciences Awards 2020 and in
2021 recognized as a Jurisdictional Winner in Hungary by LMG.
She speaks Hungarian, English and German.
Gabor Toth, M.D., Ph.D. graduated as a medical doctor at the University of Debrecen with the highest honors in 2013. He was awarded the Pro Scientia Gold medal for his outstanding student research work. As the president of the Hungarian Medical Students' International Relations Committee, he was working on improving the medical education of Hungarian students. During his Ph.D. studies, his academic research was focusing on targeted cancer immunotherapies. In a bid to reform clinical education with standardized solutions, he co-founded InSimu Ltd in 2016. As the CEO and medical director of InSimu, he provides medical students, schools and professionals worldwide with an efficient practicing and assessment tool for clinical reasoning skills.
Gábor Tóth has been diving digital transformation in companies across a variety of industries for over 20 years. Prior to Patient Record, he was the managing director of Wolters Kluwer Hungary for 8 years. He then went on to lead the company’s label division’s innovation hub. Earlier in his carrier he lead the Estonian CV-Online group through a successful exit. He was also part of the team which launched Wizz Air, where he was responsible for the airline’s digital client facing platforms.
László is a Partner in Deloitte’s Cyber Risk Services group. He has over 19 years IT security consulting experience. He performed and lead numerous IT security penetration tests and security reviews in highly sensitive areas including automotive industry, financial services, telecommunication and public sector clients.
His expert areas are various penetration testing services and incident response. He is a specialist in automotive security and has deep knowledge about a wide range of operating systems, databases, application frameworks and automotive technologies.
László has published his unique research results regarding Oracle database security and he is the developer of woraauthbf, which was the fastest Oracle password cracker at time of the publishing.
László also published his research on Android mobile forensic and encryption.
She is a survivor-mother with cervical cancer who graduated in HR and social work. Her recovery gave birth to the Mallow Flower Foundation, which works for HPV prevention and those affected by gynaecological cancer. Her mission is to rescue women, properly manage patient pathways, accompany, and support both in prevention and in the field of gynaecological tumours. Icó and the Mallow Flower were promoted to honorary members of the Hungarian Gynaecological Oncology Society. 2019-2021. Co-chair of ESGO ENGAGe / European Network of Gynaecological Cancer Advocacy Groups /. She is a member of the WHO Rehabilitation Working Group, the ASCO Ovarian Cancer Directive Working Group. The Mallow Foundation has received numerous awards (Opportunity Award, 2019; Health Promotion Civil Organization of the Year, 2019; For Population Sports / MASPORT, 2019). One of their outstanding projects: www.malyvabetegut.hu
David Uzoni started his first company at the age of 14 and was named the ‘youngest startupper in Hungary’ by Forbes magazine. During his high school years in Kuwait, he developed an app to digitalise the local public transportation system. His project was supported by the Kuwaiti royal family. David then moved to the United States and attended Bentley University. Following his studies he founded EcoHills Kereskedelmi Kft, a company that distributes and manufactures eco-friendly products for the HoReCa industry. The company became a significant player in the Hungarian market of biodegradable straws in 3 years time. In 2017 David founded DP Innovations Kft, and started developing a digital inhalation device. The inhaler, called SPRIN, collects information about asthmatic and COPD patients’ therapy adherence and peak flow values. Based on this data SPRIN recommends a personalized dose setting for the patient in real-time. The company raised funds in several rounds and their next goal is to start the sales of SPRIN as a medical device.
Varga-Tarr Sándor kommunikációs, marketing és üzletfejlesztési szakember, aki 2019 óta a Hiventures inkubációs befektetési programjának igazgatója. Oktatott hazai és nemzetközi startup képzésekben, szervezett nemzetközi üzletfejlesztési programokat, amely során befektetésekhez és kereskedelmi partnerekhez segített magyarországi startup cégeket. Vezetőként részt vett exitig eljutó fintech vállalkozásban, továbbá smart city és agritech startupokban is.
Péter Vereckei, MD, graduated from the University of Medicine in Debrecen in 2000 and later continued his education in the field of health economics and health policy at Eötvös Loránd University. After graduating, he began a 20-year career in the pharmaceutical industry working for the Hungarian subsidiary of Pfizer, starting as a Pharmaceutical Sales Rep before taking an executive position in January 2014. From 2016, he has been a member of the board of Innovative Pharmaceutical Manufacturers, and from 2018 to February 2020, he was the president of the association. An important milestone in his professional career was the establishment of the National Pharmaceutical Identification Organization, implemented with the full cooperation of the pharmaceutical industry, in which he actively participated and was a member of the organization's board.
Matt Zeller is currently leading the Hungarian organization as Country President. Previous Novartis roles include executive director of U.S. cardiovascular national hospital accounts, vice president and head of U.S. patient and specialty services, U.S. sales and marketing head of the COPD franchise, and director of global pharma strategy in Switzerland. Before joining Novartis, Matt was a principal in BCG’s New Jersey and Shanghai offices in the commercial pharma space. Prior to BCG, he worked in hospital marketing and pharma sales for Lilly. Matt holds a Bachelor of Science from Vanderbilt University and an MBA from Duke University.
During her 20+ years’ experience in the Pharmaceutical Industry, Selen has led diverse businesses and teams within and across many countries. She has a deep knowledge of country markets, structures and characteristics, not only in Central Europe, but also within other regions including Middle East, Turkey, Africa, CIS.
Selen also has extensive experience collaborating with local trade associations: she has been actively engaged throughout her career with several pharmaceutical associations; as a previous board member of Infarma in Poland, and currently a board member of AIPM in Hungary and Vice Chair for EFPIA CEE Task Force, Selen works effectively across a number of diverse industry and international stakeholder groups identifying and achieving common goals.
As a Commercial leader, a General Manager, and Head of Region, Selen has always attached great importance to interpersonal relationships, building team successes though mutual respect and ongoing, open dialogue. Her approach is focused, identifying a few clear priorities that can be excellently executed to achieve results. Using clear objective setting, collaboration between individuals and teams in order to reach consensus, Selen drives operations forward successfully that support the Merck Group strategy.
In addition to his research in digital health, biotechnology and health economic evaluation, he is a lecturer of health economics and healthcare innovation for Hungarian and international students. Prior to his academic career, Zsombor has worked in child psychiatry, and then he spent 17 years in the pharmaceutical industry in various national and international roles including sales, medical, marketing and business unit management. He has worked in the European Brand Team of Pfizer from Hungary, Germany, the UK and France. At Egis Pharmaceuticals Plc. he led the launch of the first biosimilar monoclonal antibody in a number of countries in Eastern Europe and the CIS region. He graduated as a medical doctor at the Semmelweis University, and holds and MBA from the Oxford Brookes University as well as a PhD from the Corvinus University of Budapest.